Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients

Beytullah Cakal; Sinem Cakal; Oguz Karaca; Mehmet Omaygenc; Filiz Yilmaz; Haci Gunes; Ozgur Ozcan; Arzu Yıldırım; Bilal Boztosun

doi:10.5114/aic.2020.101763

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2020
vol. 16

Send email

Copy url:

abstract:

Original paper

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients

Beytullah Cakal

¹

,

Sinem Cakal

¹

,

Oguz Karaca

¹

,

Mehmet Onur Omaygenc

¹

,

Filiz Kizilirmak Yilmaz

¹

,

Haci Murat Gunes

¹

,

Ozgur Ulas Ozcan

¹

,

Arzu Yıldırım

¹

,

Bilal Boztosun

¹

Department of Cardiology, Istanbul Medipol University, Istanbul, Turkey

Adv Interv Cardiol 2020; 16, 4 (62): 391–398

DOI: https://doi.org/10.5114/aic.2020.101763

Online publish date: 2020/12/29

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Cakal B, Cakal S, Karaca O, et al. Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020;16(4):391-398. doi:10.5114/aic.2020.101763.

APA

Cakal, B., Cakal, S., Karaca, O., Omaygenc, M. O., Yilmaz, F. K.,  & Gunes, H. M. et al. (2020). Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 16(4), 391-398. https://doi.org/10.5114/aic.2020.101763

Chicago

Cakal, Beytullah, Sinem Cakal, Oguz Karaca, Mehmet O Omaygenc, Filiz K Yilmaz, Haci M Gunes,  and Ozgur U Ozcan et al. 2020. "Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 16 (4): 391-398. doi:10.5114/aic.2020.101763.

Harvard

Cakal, B., Cakal, S., Karaca, O., Omaygenc, M., Yilmaz, F., Gunes, H., Ozcan, O., Yıldırım, A.,  and Boztosun, B. (2020). Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 16(4), pp.391-398. https://doi.org/10.5114/aic.2020.101763

MLA

Cakal, Beytullah et al. "Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 16, no. 4, 2020, pp. 391-398. doi:10.5114/aic.2020.101763.

Vancouver

Cakal B, Cakal S, Karaca O, Omaygenc M, Yilmaz F, Gunes H et al. Long-term comparison of everolimus- vs. 
novolimus-eluting bioresorbable vascular scaffolds 
in real world patients. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020;16(4):391-398. doi:10.5114/aic.2020.101763.

The largest amount of evidence for bioresorbable vascular scaffold (BVS) use in clinical practice derives from Absorb trials and registries. Comparison of Absorb BVS with metallic stents resulted in increased rates of target lesion failure and device thrombosis in the Absorb BVS group. We investigated whether all BVS platforms created equal outcomes. At 3-year follow-up novolimus-eluting BVS (Desolve Elixir Medical Corp., Sunnyvale, CA) achieved better outcomes compared with Absorb BVS. The scaffold thrombosis rate is still high with Absorb BVS despite pre- and post- dilatation. No scaffold thrombosis was present with Desolve BVS.

keywords:

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients

Beytullah Cakal 1 , Sinem Cakal 1 , Oguz Karaca 1 , Mehmet Onur Omaygenc 1 , Filiz Kizilirmak Yilmaz 1 , Haci Murat Gunes 1 , Ozgur Ulas Ozcan 1 , Arzu Yıldırım 1 , Bilal Boztosun 1

coronary artery disease, percutaneous coronary intervention, bioresorbable scaffolds

Beytullah Cakal

¹

,

Sinem Cakal

¹

,

Oguz Karaca

¹

,

Mehmet Onur Omaygenc

¹

,

Filiz Kizilirmak Yilmaz

¹

,

Haci Murat Gunes

¹

,

Ozgur Ulas Ozcan

¹

,

Arzu Yıldırım

¹

,

Bilal Boztosun

¹